Sign Up Today and Learn More About Fore Biotherapeutics Stock
Invest in or calculate the value of your shares in Fore Biotherapeutics or other pre-IPO companies through EquityZen's platform.
Fore Biotherapeutics Stock (FOBI)
Fore Biotherapeutics is a precision oncology company specializing in cancer therapies guided by functional genomics.
About Fore Biotherapeutics Stock
Founded
2011
Headquarters
Philadelphia, PA, US
Industries
Messaging and Telecommunications, Sports, Content and Publishing
Fore Biotherapeutics Press Mentions
Stay in the know about the latest news on Fore Biotherapeutics
FORE Biotherapeutics to Participate in the Raymond James Private Biotech Symposium
biospace • Feb 14, 2025
BRAF Inhibitors Market to Register Incremental Growth During the Study Period (2020–2034) | DelveInsight
globenewswire • Jan 29, 2025
FORE Biotherapeutics to Participate in Upcoming November Conferences
businesswire • Nov 07, 2024
FORE Biotherapeutics Names William R. Hinshaw as Chief Executive Officer
businesswire • Aug 14, 2024
FORE Biotherapeutics Names Michael Byrnes as Chief Financial Officer
businesswire • Aug 12, 2024
Fore Biotherapeutics Management
Leadership team at Fore Biotherapeutics
Chief Executive Officer and Board Member
Matthew Ros
CMO
Stacie Shepherd
Join now and verify your accreditation status to gain access to:
- Fore Biotherapeutics Current Valuation
- Fore Biotherapeutics Stock Price
- Fore Biotherapeutics Management
- Available deals in Fore Biotherapeutics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Fore Biotherapeutics Cap Table and Funding History by Share Class and Liquidity Preferences
- Fore Biotherapeutics Revenue and Financials
- Fore Biotherapeutics Highlights
- Fore Biotherapeutics Business Model
- Fore Biotherapeutics Risk Factors
- Fore Biotherapeutics Research Report from SACRA Research
Trading Fore Biotherapeutics Stock
How to invest in Fore Biotherapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Fore Biotherapeutics through EquityZen funds. These investments are made available by existing Fore Biotherapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Fore Biotherapeutics stock?
Shareholders can sell their Fore Biotherapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
